Complete remission achieved with angiogenic therapy in metastatic renal cell carcinoma including surgical intervention

Urologic Oncology: Seminars and Original Investigations

Volumn 28, Issue 2, 2010, Pages 139-144

  Staehler, Michael ^a   Haseke, Nico ^a   Zilinberg, Ekaterina ^a   Stadler, Thomas ^a   Karl, Alexander ^a   Siebels, Michael ^a   Dürr, Hans Roland ^a   Siegert, Sabine ^a   Jauch, Karl W ^a   Bruns, Christiane J ^a   Stief, Christian G ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Metastasectomy; Renal cell cancer; Sorafenib; Sunitinib; Survival

Indexed keywords

ALPHA INTERFERON; SORAFENIB; SUNITINIB;

ADRENALECTOMY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CONTINUOUS INFUSION; DATA BASE; DRUG DOSE REDUCTION; FEMALE; HAND FOOT SYNDROME; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY CARCINOMA; KIDNEY METASTASIS; LIVER METASTASIS; LUNG METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEPHRECTOMY; PATIENT ASSESSMENT; PRIORITY JOURNAL; REMISSION;

AGED; ANGIOGENESIS INHIBITORS; BENZENESULFONATES; CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INDOLES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; PYRIDINES; PYRROLES; REMISSION INDUCTION;

EID: 77249127890     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.03.033     Document Type: Article

References (16)

1. SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER web site [database on the Internet] 2008.
2. Motzer R.J., Hutson T.E., Tomczak P., et al. Sunitinib versus interferon-α in metastatic renal-cell carcinoma. N Engl J Med 356 (2007) 115-124
3. Escudier B., Eisen T., Stadler W.M., et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356 (2007) 125-134
4. Staehler M., Stenzl A., Dietrich P.Y., et al. A phase I study to evaluate safety, immunogenicity and anti-tumor activity of the multi-peptide vaccine IMA901 in renal cell carcinoma patients (RCC). Proceedings of the 2007 ASCO Annual Meeting, June, Chicago, IL. J Clin Oncol 25 Suppl June 20 (2007) 18S 5098
5. McDermott D.F., Regan M.M., Clark J.I., et al. Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma. J Clin Oncol 23 (2005) 133-141
6. Atzpodien J., Kirchner H., Jonas U., et al. Interleukin-2- and interferon α-2a-based immunochemotherapy in advanced renal cell carcinoma: A Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). J Clin Oncol 22 (2004) 1188-1194
7. McDermott D.F., and Atkins M.B. Application of IL-2 and other cytokines in renal cancer. Expert Opin Biol Ther 4 (2004) 455-468
8. Knox J.J., Figlin R.A., Stadler W.M., et al. The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial in North America: Safety and efficacy. Proceedings of the 2007 ASCO Annual Meeting, Part I. J Clin Oncol 25 Suppl June 20 (2007) 18S 5011
9. Gore M.E., Porta C., Oudard S., et al. Sunitinib in metastatic renal cell carcinoma (mRCC): Preliminary assessment of toxicity in an expanded access trial with subpopulation analysis. Proceedings of the 2007 ASCO Annual Meeting, Part I. J Clin Oncol 25 Suppl June 20 (2007) 18S 5010
10. Amato R.J., Harris P., Dalton M., et al. A phase II trial of intra-patient dose-escalated sorafenib in patients (pts) with metastatic renal cell cancer (MRCC). Proceedings of the 2007 ASCO Annual Meeting, Part I. J Clin Oncol 25 Suppl June 20 (2007) 18S 5026
11. Heng D.Y., Rini B.I., Garcia J., et al. Prolonged complete responses and near-complete responses to sunitinib in metastatic renal cell carcinoma. Clin Genitourin Cancer 5 (2007) 446-451
12. Rini B.I., Shaw V., Rosenberg J.E., et al. Patients with metastatic renal cell carcinoma with long-term disease-free survival after treatment with sunitinib and resection of residual metastases. Clin Genitourin Cancer 5 (2006) 232-234
13. Motzer R.J., Bacik J., Schwartz L.H., et al. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol 22 (2004) 454-463
14. Durr H.R., Maier M., Pfahler M., et al. Surgical treatment of osseous metastases in patients with renal cell carcinoma. Clin Orthop 367 (1999) 283-290
15. Piltz S., Meimarakis G., Wichmann M.W., et al. Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 73 (2002) 1082-1087
16. Thelen A., Jonas S., Benckert C., et al. Liver resection for metastases from renal cell carcinoma. World J Surg 31 (2007) 802-807